This metabolic disease involves defects in insulin secretion and action, and is closely linked to obesity, genetic factors, and metabolic inflammation, and its complex pathologic mechanisms are driving the deepening of cutting-edge research in endocrine medicine. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.